“…Actinomycin D (ActD), Brij 98, Coomassie blue R250, crystal violet, glutathione agarose beads, propidium iodide (PI), gelatin type B, paraformaldehyde, 1,4‐diamino‐2,3‐dicyano‐1,4‐bis(methylthio) butadiene (U0126), 2‐(4‐morpho‐linyl)‐8‐phenyl‐4H‐1‐benzopyran‐4‐one (LY294002), 4‐(4‐fluorophenyl)‐2‐(4‐hydroxyphenyl)‐5‐(4‐pyridyl) 1H‐imidazole (SB202190), 1,9‐pyrazoloanthrone (SP600125), 8‐[4‐(1‐aminocyclobutyl) phenyl]‐9‐phenyl‐1,2,4‐triazolo[3,4‐f] naphthyridin‐3(2H)‐one dihydrochloride (MK‐2206), pyrrolidine dithiocarbamate (PDTC), Tris‐HCl, Triton X‐100, 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyltetrazolium bromide (MTT), and N‐ p ‐tosyl‐ L ‐phenyl‐alanine chloromethyl ketone (TPCK) were obtained from Sigma–Aldrich (St. Louis, MO). TSWU‐CD4 was prepared as previously described . DMSO and potassium phosphate were purchased from Merck (Darmstadt, Germany).…”